文献速递糖尿病

循环微小RNA作为青年起病2型糖尿病β细胞功能的预测因子:TODAY研究

Circulating MicroRNAs as Predictors of Beta Cell Function in Youth-onset Type 2 Diabetes: The TODAY Study.
PubMed 文献 · J Clin Endocrinol Metab · 2024-01-01

在TODAY研究中,对365名青年起病2型糖尿病参与者基线和随访至120个月的17种微小RNA进行PCR分析。基线miRNA-155和miRNA-130b水平升高与C肽口服处置指数下降相关,miRNA-126水平降低亦相关;miRNA-122与C肽口服处置指数和胰岛素原相关。结论认为基线丰度差异可能作为β细胞功能障碍的循环标志物。

要点

  • 基线miRNA-155升高与C肽口服处置指数下降≥20%相关(OR 1.2,95%CI 1.1-1.4)。
  • 基线miRNA-130b升高与C肽口服处置指数下降相关(OR 1.3,95%CI 1.0-1.7)。
  • 基线miRNA-126降低与C肽口服处置指数下降相关(OR 0.6,95%CI 0.4-0.8)。

核心结论

  • 与β细胞功能相关的miRNA种类与细胞代谢和凋亡改变相关,提示基线丰度差异可能作为β细胞功能障碍的循环标志物,并为青年起病2型糖尿病的侵袭性提供潜在机制见解。

研究设计与样本

  • TODAY研究为干预试验后接观察期,本分析对365名参与者的基线、24、60、96和120个月样本进行17种miRNA的聚合酶链反应分析,此前使用nCounter Human v3 miRNA Panel对部分参与者进行初步调查。

主要发现

  • 采用后向选择法,4种基线miRNA log2倍数变化独立预测治疗失败,但治疗失败者基线HbA1c更高。
  • 3种基线miRNA log2倍数变化仍显著预测C肽口服处置指数下降≥20%(P < .05)。
  • miRNA-155水平升高与口服处置指数下降相关(OR 1.2,95%CI 1.1-1.4)。
  • miRNA-130b水平升高与口服处置指数下降相关(OR 1.3,95%CI 1.0-1.7)。
  • miRNA-126水平降低与口服处置指数下降相关(OR 0.6,95%CI 0.4-0.8)。

关键数值与推荐

  • miRNA-122与基线C肽口服处置指数负相关(R = 0.22,P < .01),与24个月C肽口服处置指数负相关(R = 0.19,P < .01)。
  • miRNA-122与基线胰岛素原正相关(R = 0.26,P < 0.01),与24个月胰岛素原正相关(R = 0.26,P < .01),与60个月胰岛素原正相关(R = 0.18,P < .01)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: In the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) study, an intervention trial followed by an observational phase, half the participants reached the primary outcome [hemoglobin A1c (HbA1c) ≥ 8% for at least 6 months] within 4 years, which was associated with a decrease in C-peptide oral disposition index (oDI). We aimed to identify circulating microRNA (miRNA) species associated with a decline in beta cell function. METHODS: Following a preliminary survey of select participants using nCounter Human v3 miRNA Panel (NanoString Technologies), polymerase chain reaction analyses were carried out for 17 miRNAs from 365 participants from samples at baseline, 24, 60, 96, and 120 months. RESULTS: Using a backward selection approach, 4 baseline miRNA log2 fold-changes independently predicted treatment failure; however, baseline HbA1c was higher in those with treatment failure. Three baseline miRNA log2 fold-changes remained significant predictors of this C-peptide oDI decline ≥20% (P < .05). Increased levels of miRNA-155 [odds ratio (OR): 1.2, 95% confidence interval (CI): 1.1-1.4] and miRNA-130b (OR:1.3, 95% CI: 1.0-1.7) were associated with oDI decline, while decreased levels of miRNA-126 (OR: 0.6, 95% CI: .4-.8) were associated with oDI decline. miRNA-122 was negatively correlated with C-peptide oDI at baseline and 24 months (R = 0.22, P < .01 and R = 0.19, P < .01, respectively) and positively correlated with proinsulin at baseline, 24, and 60 months (R = 0.26, P < 0.01, R = 0.26, P < .01, R = 0.18, P < .01, respectively). CONCLUSION: The miRNA species associated with beta cell function are associated with alterations in cellular metabolism and apoptosis, suggesting that differences in baseline abundance may serve as circulating markers of beta cell dysfunction and provide potential mechanistic insights into the aggressive nature of youth-onset type 2 diabetes.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Redling D, Bialak S, El Ghormli L, et al. Circulating MicroRNAs as Predictors of Beta Cell Function in Youth-onset Type 2 Diabetes: The TODAY Study. J Clin Endocrinol Metab. 2024. PMID: 38815053. doi:10.1210/clinem/dgae376

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。